Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX000197 vs Cisplatin in Malignant Pleural Effusion
NCT07649369Phase 2Not yet recruiting
- Sponsor
- Jeyou Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX000197 in malignant pleural effusion (MPE), sponsored by Jeyou Pharmaceutical. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
JMKX000197
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT07649369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07649369.